Skip to content Skip to navigation

NINDS Efficacy Clinical Trials (U01) PAR-17-102

National Institutes of Health
Funding Sponsor: 
National Institutes of Health
Contact Email:
Funding Deadline: 
May 7, 2018 - 11:59 pm

NINDS Efficacy Clinical Trials (U01) PAR-17-102

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for  investigator-initiated clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS) to establish the efficacy (or compare the effectiveness) of treatment interventions.  These Phase 3, Phase 4 or Pivotal trials must address questions within the mission and research interests of the NINDS and may include studies of drugs, biologics, and devices, as well as surgical, behavioral or rehabilitation therapies.

Standard U01 deadlines: Feb. 5, June 5, Oct. 5

Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7

Expiration date: Jan. 8, 2020

Learn more